Year: 2014
Type: review
Abstract: Achieving adequate glucose control in critically ill patients is a complex but important part of optimal patient management. Until relatively recently, intermittent measurements of blood glucose have been the only means of monitoring blood glucose levels. With growing interest in the possible beneficial effects of continuous over intermittent monitoring and the development of several continuous glucose monitoring (CGM) systems, a round table conference was convened to discuss and, where possible, reach consensus on the various aspects related to glucose monitoring and management using these systems. In this report, we discuss the advantages and limitations of the different types of devices available, the potential advantages of continuous over intermittent testing, the relative importance of trend and point accuracy, the standards necessary for reporting results in clinical trials and for recognition by official bodies, and the changes that may be needed in current glucose management protocols as a result of a move towards increased use of CGM. We close with a list of the research priorities in this field, which will be necessary if CGM is to become a routine part of daily practice in the management of critically ill patients.
Source: Critical Care
DOI: 10.1186/cc13921
Institutions: Karolinska University Hospital, University of Liège, The University of Sydney, Royal North Shore Hospital, The George Institute for Global Health, Onze Lieve Vrouwziekenhuis Hospital, Medical University of Vienna, University of Cambridge, Wellcome/MRC Institute of Metabolic Science, Addenbrooke's Hospital, Wellcome Trust, Thomas Jefferson University, Thomas Jefferson University Hospital, Saint Luke's Hospital, University of Missouri–Kansas City, Stamford Hospital, Columbia University, Universitair Ziekenhuis Leuven, Tufts Medical Center, Karolinska Institutet, Amsterdam UMC Location University of Amsterdam, University of Amsterdam, iMinds, KU Leuven, Walter Reed National Military Medical Center, Université Libre de Bruxelles, Erasmus Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,190
OpenAlex ID: W2059670330